Attention and Impulsive Choice Can Recover Differently During Methamphetamine Treatment

A small longitudinal study found improvement in sustained attention during methamphetamine treatment while stronger preference for immediate rewards persisted. Treating cognition as a single ability would conceal that difference.

What was followed over time

Bernhardt and colleagues recruited 30 methamphetamine-dependent patients and 24 non-substance-abusing comparison participants matched on age, sex and education. Baseline testing measured sustained attention and delay discounting. Patients entered a methamphetamine-specific relapse-prevention program, and both groups were assessed again after three months.

Two outcomes followed different patterns

Patients initially made more omissions on the attention task. Their omission counts later decreased to the comparison group’s level. In contrast, patients discounted delayed rewards more strongly at both assessments. Improvement in noticing targets therefore did not demonstrate equal improvement in willingness to wait for a reward.

Monitoring exposure was not measuring impairment

Urine testing supported relapse monitoring during treatment. The program used a specified reporting cutoff for methamphetamine and amphetamines, but that operational exposure measure was not an impairment threshold. A urine result does not quantify brain drug effect during a cognitive task.

Why treatment causation remains uncertain

The investigation was a longitudinal case-control study, not random allocation to the program versus an equivalent untreated patient group. The authors explicitly lacked an intervention control group. Time, abstinence, treatment participation and selection of people completing follow-up may all contribute to observed changes. The small sample and short follow-up further limit certainty. The defensible conclusion is domain-specific improvement in this cohort, with persistent differences in another measured domain; neither universal cognitive recovery nor proof of present intoxication follows.

Related evidence

For a different perspective on interpreting stimulant evidence, see our analysis of Stroop findings across abstinence intervals. Its study population and outcome should remain separate from the present findings.

Primary research

Neurocognitive Dysfunctions and Their Therapeutic Modulation in Patients With Methamphetamine Dependence: A Pilot Study. Original human research. doi:10.3389/fpsyt.2020.00581.